Clinical Decision Support Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Clinical Decision Support Systems Market is Segmented by Model (Knowledge-based CDSS and Non-knowledge CDSS), Mode of Delivery (Cloud-based and On-premise), Component (Hardware, Software, and Services), Product (Integrated CDSS and Standalone CDSS), Application (Medical Diagnosis, Alerts and Reminders, Prescription Decision Support, Information Retrieval, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Clinical Decision Support Systems Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.4 %
Clinical Decision Support Systems Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The clinical decision support systems market was valued at approximately USD 1,686.3 million in 2021, and it is expected to reach USD 2,819.50 million by 2027, registering a CAGR of nearly 9.4% during the forecast period (2022-2027).

Amid the COVID-19 pandemic, the health systems of countries are majorly dependent on online services. Through video calls, patients are getting appointments with doctors, which is helping in treating and monitoring the diseases, thereby propelling the clinical decision support systems market.

According to the World Aging 2019 Report, it was estimated that there were 703 million persons aged 65 years or over in the world in 2019. This group of the population mainly suffers from a lot of chronic diseases and needs regular health checks and treatments for the prevention of diseases. Based on the current situation across the world, there may be a lot of people, such as the elderly population and pregnant women, who may need health checks. However, due to the COVID-19 outbreak across the world, hospitals and clinics are unable to provide services. Several countries are increasingly providing online services, which is boosting the market.

Moreover, the healthcare facilities, such as hospitals, diagnostic centers, and clinics, are showing interest in clinical decision support systems in minimizing medication prescription errors, adverse drug events monitoring, and other medical errors.

The rising demand for reducing healthcare expenditure, the need for improvement in the quality of care, and technological advancements in healthcare IT in hospitals are the major factors that are likely to boost the growth of the clinical decision support systems (CDSS) market.

Furthermore, according to the Organization for Economic Co-operation and Development (OECD) Survey Report, in 2020, the average per capita health expenditure was about USD 6,730.9 in Germany, USD 6,748.4 in Norway, and USD 5,753.6 in Sweden. Due to high healthcare expenditure across the world, the rising demand to reduce healthcare expenditure has a positive impact on the market.

According to the study published in January 2020, named "Development and use of a clinical decision support system for the diagnosis of social anxiety disorder,” the hybrid optimization learning algorithm had the accuracy, sensitivity, and specificity metrics. The results revealed that the proposed model was quite appropriate for SAD diagnosis and in line with the findings of other studies.

However, lack of trust in the systems, as CDSS are in the initial stages of development, lack of skilled labor, and suggestions from CDSS for unnecessary diagnostic testing hinder the market growth.

Scope of the Report

As per the scope of the report, clinical decision support systems (CDSS) refer to healthcare IT systems designed specifically to assist clinical decision support for healthcare professionals and physicians. They include various tools that help enhance decision-making in the clinical workflow. Additionally, they provide computerized alerts and reminders to care providers and patients, clinical guidelines, focused patient data reports and summaries, diagnostic support, and documentation templates, among other tools.

The clinical decision support systems market is segmented by the model (knowledge-based CDSS and non-knowledge CDSS), mode of delivery (cloud-based and on-premise), component (hardware, software, and services), product (integrated CDSS and standalone CDSS), application (medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Model
Knowledge-based CDSS
Non-knowledge CDSS
By Mode of Delivery
Cloud-based
On-premise
By Component
Hardware
Software
Services
By Product
Integrated CDSS
Standalone CDSS
By Application
Medical Diagnosis
Alerts and Reminders
Prescription Decision Support
Information Retrieval
Other Applications
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Cloud-based Segment is Expected to Hold a Major Market Share

The increasing healthcare expenditure and adoption of cloud computing are the major drivers for the expansion of the cloud-based segment of the market. The government in various countries in the European region are taking initiatives to support the growth of information technology in healthcare. For instance, in February 2021, as the UK government launched an initiative to adopt a fully connected cloud-driven health service, over two million National Health Services (NHS) mail mailboxes were moved to Exchange Online, which is a part of Microsoft’s Azure Cloud. This will enable smoother and more efficient communication between staff across NHS organizations and departments and provide improved access to information. This will increase the usage of (Healthcare Information Technology) HCIT Change Management services in the United Kingdom and boost the market's growth.

Furthermore, local knowledge management of clinical decision support systems (CDSS) may require extensive processing power and storage capacity, which can result in high operating costs. In contrast, cloud-based applications are operated in remote servers, and executing them does not require a large amount of computational power or large storage space in the user’s device.

Cloud-based applications do not depend on web browsers, which makes them inherently safer than web-based applications. In a cloud-based clinical decision support system, processing units are hosted on remote servers, which can be located in multiple data centers across the world, making them less vulnerable to cyberattacks. The increasing availability of cloud technology, owing to their benefit, is expected to drive the usage of cloud-based CDSS over the forecast period.

Clinical Decision Support Systems Market Share

North America is Expected to Hold a Significant Share in the Market in the Forecast Period

The clinical decision support systems (CDSS) market in North America is driven due to the rise in the technological advancement in CDSS, high awareness rate among patients, and rising investments in healthcare IT solutions in the region.

As per the Centers for Disease Control and Prevention (CDC) 2019, 6 in 10 Americans have at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These chronic diseases are the leading causes of death and disability in the United States, and they are also a leading driver of healthcare costs. Moreover, according to the Organization for Economic Co-operation and Development (OECD) Survey Report, in 2019, the average per capita health expenditure in the United States was about USD 11,072.

In 2019, a paper published in the American Journal of Managed Care named “Trends in the Use of Clinical Decision Support by Health System–Affiliated Ambulatory Clinics in the United States,” the rate of usage of clinical decision support systems increased in ambulatory clinics. Thus, the increase in adoption and usage rate in the country will drive the market's growth in the future.

These initiatives may fuel the growth of the CDSS market over the forecast period in North America.

Clinical Decision Support Systems Market Growth

Competitive Landscape

The clinical decision support systems market has the presence of well-diversified international, regional, and local players. However, some big international players dominate the market, owing to their brand image and market reach. The market is consolidated and competitive. The market players are continuously focusing on acquisitions, mergers, provision of customized solutions, and expansions in the untapped commercial markets. Moreover, companies are investing huge amounts in developing new products and platforms with enhanced and improved features as a part of the commercialization strategy.

Recent Developments

In October 2020, WeHealth Digital Medicine, Servier Group's e-health business unit, and CureMatch, a leader in digital health precision medicine, announced that they had received CE Mark approval for Bionov. Bionov is a clinical decision support software platform that presents healthcare professionals with personalized single drug and combination drug treatment options based primarily on the molecular profile of their cancer patients.

In March 2020, IBM Watson Health and EBSCO Information Services announced a strategic collaboration aimed toward enhancing clinical decision support (CDS) and operations for healthcare providers and health systems. The companies are combining their respective solution suites into a single, high-value global solution called DynaMed and Micromedex with Watson. The combined solution suite is designed to bring together drug and disease content into a single source for evidence-based insights.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancement in Healthcare IT in Hospitals

      2. 4.2.2 Rising Demand to Reduce Healthcare Expenditure

      3. 4.2.3 Need for Improvement in Quality of Care and Reducing Human Errors

    3. 4.3 Market Restraints

      1. 4.3.1 Privacy and Data Security Concerns Related to Cloud-based CDSS

      2. 4.3.2 Lack of Skilled Professionals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Model

      1. 5.1.1 Knowledge-based CDSS

      2. 5.1.2 Non-knowledge CDSS

    2. 5.2 By Mode of Delivery

      1. 5.2.1 Cloud-based

      2. 5.2.2 On-premise

    3. 5.3 By Component

      1. 5.3.1 Hardware

      2. 5.3.2 Software

      3. 5.3.3 Services

    4. 5.4 By Product

      1. 5.4.1 Integrated CDSS

      2. 5.4.2 Standalone CDSS

    5. 5.5 By Application

      1. 5.5.1 Medical Diagnosis

      2. 5.5.2 Alerts and Reminders

      3. 5.5.3 Prescription Decision Support

      4. 5.5.4 Information Retrieval

      5. 5.5.5 Other Applications

    6. 5.6 By Geography

      1. 5.6.1 North America

        1. 5.6.1.1 United States

        2. 5.6.1.2 Canada

        3. 5.6.1.3 Mexico

      2. 5.6.2 Europe

        1. 5.6.2.1 Germany

        2. 5.6.2.2 United Kingdom

        3. 5.6.2.3 France

        4. 5.6.2.4 Italy

        5. 5.6.2.5 Spain

        6. 5.6.2.6 Rest of Europe

      3. 5.6.3 Asia-Pacific

        1. 5.6.3.1 China

        2. 5.6.3.2 Japan

        3. 5.6.3.3 India

        4. 5.6.3.4 Australia

        5. 5.6.3.5 South Korea

        6. 5.6.3.6 Rest of Asia-Pacific

      4. 5.6.4 Middle-East and Africa

        1. 5.6.4.1 GCC

        2. 5.6.4.2 South Africa

        3. 5.6.4.3 Rest of Middle-East and Africa

      5. 5.6.5 South America

        1. 5.6.5.1 Brazil

        2. 5.6.5.2 Argentina

        3. 5.6.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cerner Corporation

      2. 6.1.2 Epic Systems Corporation

      3. 6.1.3 IBM

      4. 6.1.4 Change Healthcare

      5. 6.1.5 Medical Information Technology Inc.

      6. 6.1.6 Koninklijke Philips NV

      7. 6.1.7 Siemens Healthcare

      8. 6.1.8 Allscripts Healthcare Solutions Inc.

      9. 6.1.9 Wolters Kluwer NV

      10. 6.1.10 Mckesson Corporation

      11. 6.1.11 Zynx Health Inc.

      12. 6.1.12 Elsevier

      13. 6.1.13 NextGen Healthcare Inc.

      14. 6.1.14 Agfa-Gevaert Group

      15. 6.1.15 Athenahealth Inc.

      16. 6.1.16 VisualDx

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Clinical Decision Support Systems Market market is studied from 2019 - 2027.

The Clinical Decision Support Systems Market is growing at a CAGR of 9.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Siemens Healthcare, Koninklijke Philips NV, IBM, Cerner Corporation, Change Healthcare are the major companies operating in Clinical Decision Support Systems Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!